Capital Fund Management S.A. purchased a new position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 15,858 shares of the business services provider's stock, valued at approximately $1,285,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brooklyn Investment Group boosted its position in shares of Exponent by 10,200.0% during the first quarter. Brooklyn Investment Group now owns 309 shares of the business services provider's stock worth $25,000 after purchasing an additional 306 shares in the last quarter. Whipplewood Advisors LLC boosted its position in shares of Exponent by 5,333.3% during the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock worth $26,000 after purchasing an additional 320 shares in the last quarter. UMB Bank n.a. boosted its position in shares of Exponent by 859.1% during the first quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock worth $51,000 after purchasing an additional 567 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of Exponent by 103.3% during the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock worth $55,000 after purchasing an additional 346 shares in the last quarter. Finally, Johnson Financial Group Inc. bought a new position in shares of Exponent during the fourth quarter worth $59,000. 92.37% of the stock is owned by institutional investors.
Exponent Price Performance
Shares of NASDAQ EXPO traded down $0.85 during midday trading on Friday, reaching $71.38. 357,500 shares of the stock were exchanged, compared to its average volume of 463,763. The business has a 50-day simple moving average of $72.56 and a two-hundred day simple moving average of $77.32. The company has a market capitalization of $3.60 billion, a price-to-earnings ratio of 35.69 and a beta of 0.89. Exponent, Inc. has a 12 month low of $63.81 and a 12 month high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The company had revenue of $132.87 million for the quarter, compared to analysts' expectations of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period last year, the firm posted $0.57 earnings per share. Equities research analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Friday, September 5th. Exponent's payout ratio is currently 60.00%.
Insider Buying and Selling at Exponent
In related news, VP Joseph Sala sold 1,595 shares of the business's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total value of $112,670.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Catherine Corrigan sold 4,896 shares of the business's stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $71.09, for a total transaction of $348,056.64. Following the completion of the sale, the chief executive officer directly owned 81,342 shares in the company, valued at $5,782,602.78. This represents a 5.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.